Mave Health

About Mave Health

Mave is a company focused on enhancing mental well-being through a wearable device designed to improve mood, focus, and stress regulation using targeted, low-intensity electrical signals (tDCS). Their mission is to break the mold and help users become 'Mavericks' by integrating brain training into modern life with just 20 minutes a day.

Products & Services

Mave Wearable:A lightweight tDCS headset (~100 grams) designed to enhance mood, focus, and stress regulation in 20-minute daily sessions. It strengthens the prefrontal cortex with extensively researched, safe protocols offering compounding benefits for long-term improvement.

Specialties

Transcranial Direct Current Stimulation (tDCS) Mental Wellness Brain Training Stress Regulation Mood Enhancement Focus Improvement

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 2100000 MR: - FA: $2.1M FAN: 2100000	D: 2026-03-18 FD: 2026-03-18	4 investors

Seed Latest

2026-03-18

$2.1M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Steev Hodgson

ADHD Coach

N

Nishtha Shukla

Product Designer

A

Aaron Hoffman

Founder

M

Michael Raspuzzi

Founder

M

Max 'Pain' Griffin

UFC Fighter

R

Raisa Tolia

Content Creator

View 4 more team members with Pro

Unlock Full Team Directory

Recent News

Mave Health Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised